Found: 26
Select item for more details and to access through your institution.
Allergen sensitization stratifies IL-31 production by memory T cells in atopic dermatitis patients.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1124018
- By:
- Publication type:
- Article
SEB‐induced IL‐13 production in CLA<sup>+</sup> memory T cells defines Th2 high and Th2 low responders in atopic dermatitis.
- Published in:
- Allergy, 2022, v. 77, n. 11, p. 3448, doi. 10.1111/all.15424
- By:
- Publication type:
- Article
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 6, p. 1481, doi. 10.1007/s13555-022-00734-w
- By:
- Publication type:
- Article
Efficacy of Dupilumab in Atopic Dermatitis: The Patient's Perspective.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 6, p. 2123, doi. 10.1007/s13555-021-00621-w
- By:
- Publication type:
- Article
Itch and Sleep Improvements with Baricitinib in Patients with Atopic Dermatitis: A Post Hoc Analysis of 3 Phase 3 Studies.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 3, p. 971, doi. 10.1007/s13555-021-00534-8
- By:
- Publication type:
- Article
A re‐assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight.
- Published in:
- Contact Dermatitis (01051873), 2024, v. 91, n. 3, p. 228, doi. 10.1111/cod.14639
- By:
- Publication type:
- Article
2‐Hydroxyethyl methacrylate (2‐HEMA) sensitization, a global epidemic at its peak in Spain?
- Published in:
- Contact Dermatitis (01051873), 2024, v. 90, n. 5, p. 507, doi. 10.1111/cod.14520
- By:
- Publication type:
- Article
Sensitization to textile dyes in Spain: Epidemiological situation (2019–2022).
- Published in:
- Contact Dermatitis (01051873), 2024, v. 90, n. 5, p. 486, doi. 10.1111/cod.14513
- By:
- Publication type:
- Article
Sensitization to isothiazolinones in the Spanish Contact Dermatitis Registry (REIDAC): 2019–2021 epidemiological situation.
- Published in:
- Contact Dermatitis (01051873), 2023, v. 88, n. 3, p. 212, doi. 10.1111/cod.14251
- By:
- Publication type:
- Article
Vulvar allergic contact dermatitis caused by Magnolia officinalis bark extract.
- Published in:
- Contact Dermatitis (01051873), 2022, v. 87, n. 1, p. 96, doi. 10.1111/cod.14101
- By:
- Publication type:
- Article
Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis.
- Published in:
- JEADV Clinical Practice, 2024, v. 3, n. 1, p. 191, doi. 10.1002/jvc2.275
- By:
- Publication type:
- Article
Photoallergic contact dermatitis caused by benzophenones in magazine inks.
- Published in:
- Contact Dermatitis (01051873), 2013, v. 69, n. 2, p. 124, doi. 10.1111/cod.12072
- By:
- Publication type:
- Article
Skin reaction to hydroxyzine (Atarax<sup>®</sup>): patch test utility.
- Published in:
- 2006
- By:
- Publication type:
- Other
Use of patch test in fixed drug eruption due to metamizole (Nolotil<sup>®</sup>).
- Published in:
- 2006
- By:
- Publication type:
- Other
Metal-induced generalized pruriginous dermatitis and endovascular surgery.
- Published in:
- Contact Dermatitis (01051873), 2000, v. 43, n. 1, p. 35, doi. 10.1034/j.1600-0536.2000.043001035.x
- By:
- Publication type:
- Article
Efficacy and safety of lebrikizumab in moderate-to-severe atopic dermatitis: 52-week results of two randomized double-blinded placebo-controlled phase III trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, n. 6, p. 740, doi. 10.1093/bjd/ljad022
- By:
- Publication type:
- Article
Manejo de la urticaria en urgencias: recomendaciones de un grupo multidisciplinar de expertos.
- Published in:
- Emergencias, 2021, v. 33, n. 4, p. 299
- By:
- Publication type:
- Article
Documento de información y consenso para el manejo diagnóstico y terapéutico del prurito asociado a la enfermedad renal crónica en pacientes en hemodiálisis en España.
- Published in:
- Nefrologia, 2024, v. 44, n. 4, p. 465, doi. 10.1016/j.nefro.2023.04.006
- By:
- Publication type:
- Article
Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey.
- Published in:
- Dermatology Research & Practice, 2020, p. 1, doi. 10.1155/2020/1524293
- By:
- Publication type:
- Article
Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials.
- Published in:
- British Journal of Dermatology, 2024, v. 190, n. 2, p. 289, doi. 10.1093/bjd/ljad435
- By:
- Publication type:
- Article
Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
- Published in:
- Clinical & Experimental Dermatology, 2023, v. 48, n. 9, p. 991, doi. 10.1093/ced/llad153
- By:
- Publication type:
- Article
Sodium metabisulfite a current low relevant allergen in Spain.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 6, p. e504, doi. 10.1111/jdv.19702
- By:
- Publication type:
- Article
Chronic prurigo: Insufficient disease control in spite of high healthcare usage.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 6, p. e808, doi. 10.1111/jdv.18903
- By:
- Publication type:
- Article
Allergic contact dermatitis to alkyl glucosides: Epidemiological situation in Spain.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 3, p. e334, doi. 10.1111/jdv.18595
- By:
- Publication type:
- Article
Assessment of potential predictive factors of dupilumab response in patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- Australasian Journal of Dermatology, 2024, v. 65, n. 2, p. 153, doi. 10.1111/ajd.14196
- By:
- Publication type:
- Article
Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis.
- Published in:
- Pharmaceutics, 2023, v. 15, n. 2, p. 385, doi. 10.3390/pharmaceutics15020385
- By:
- Publication type:
- Article